SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-329068
Filing Date
2021-11-15
Accepted
2021-11-15 08:51:22
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d252724d10q.htm   iXBRL 10-Q 1890373
2 EX-31.1 d252724dex311.htm EX-31.1 10557
3 EX-31.2 d252724dex312.htm EX-31.2 10549
4 EX-32.1 d252724dex321.htm EX-32.1 4442
5 EX-32.2 d252724dex322.htm EX-32.2 4443
  Complete submission text file 0001193125-21-329068.txt   6832254

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA abos-20210930.xsd EX-101.SCH 57804
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abos-20210930_cal.xml EX-101.CAL 33100
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abos-20210930_def.xml EX-101.DEF 307697
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abos-20210930_lab.xml EX-101.LAB 402879
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abos-20210930_pre.xml EX-101.PRE 368501
11 EXTRACTED XBRL INSTANCE DOCUMENT d252724d10q_htm.xml XML 925568
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40551 | Film No.: 211406664
SIC: 2836 Biological Products, (No Diagnostic Substances)